| Primary |
| Depression |
56.7% |
| Product Used For Unknown Indication |
8.2% |
| Anxiety |
5.7% |
| Major Depression |
4.9% |
| Hypertension |
3.6% |
| Bipolar Disorder |
3.5% |
| Obsessive-compulsive Disorder |
3.0% |
| Pain |
2.8% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
| Asthma |
1.1% |
| Migraine |
1.1% |
| Insomnia |
1.0% |
| Affective Disorder |
0.9% |
| Fibromyalgia |
0.9% |
| Sleep Disorder |
0.9% |
| Back Pain |
0.9% |
| Diabetes Mellitus |
0.9% |
| Psychotic Disorder |
0.9% |
| Schizophrenia |
0.9% |
| Hiv Infection |
0.8% |
|
| Foetal Exposure During Pregnancy |
33.3% |
| Talipes |
7.7% |
| Ventricular Septal Defect |
7.2% |
| Maternal Exposure During Pregnancy |
6.3% |
| Vomiting |
5.6% |
| Suicidal Ideation |
4.8% |
| Drug Exposure During Pregnancy |
4.2% |
| Suicide Attempt |
4.2% |
| Weight Increased |
3.3% |
| Completed Suicide |
2.9% |
| Drug Ineffective |
2.5% |
| Drug Interaction |
2.5% |
| Tremor |
2.4% |
| Death |
2.2% |
| Weight Decreased |
2.2% |
| Congenital Anomaly |
2.1% |
| Therapeutic Response Unexpected With Drug Substitution |
1.8% |
| Pulmonary Valve Stenosis |
1.7% |
| Atrial Septal Defect |
1.5% |
| Drug Withdrawal Syndrome Neonatal |
1.5% |
|
| Secondary |
| Depression |
34.7% |
| Product Used For Unknown Indication |
11.5% |
| Drug Use For Unknown Indication |
9.9% |
| Anxiety |
9.7% |
| Migraine |
3.8% |
| Bipolar Disorder |
3.5% |
| Major Depression |
3.4% |
| Multiple Sclerosis |
3.2% |
| Obsessive-compulsive Disorder |
2.5% |
| Insomnia |
2.4% |
| Hypertension |
2.4% |
| Pain |
2.1% |
| Sleep Disorder |
1.6% |
| Foetal Exposure During Pregnancy |
1.6% |
| Schizophrenia |
1.5% |
| Ill-defined Disorder |
1.4% |
| Back Pain |
1.3% |
| Bipolar I Disorder |
1.3% |
| Attention Deficit/hyperactivity Disorder |
1.2% |
| Rheumatoid Arthritis |
1.2% |
|
| Weight Increased |
14.5% |
| Foetal Exposure During Pregnancy |
10.0% |
| Vomiting |
9.2% |
| Suicide Attempt |
7.2% |
| Suicidal Ideation |
7.1% |
| Weight Decreased |
6.2% |
| Drug Ineffective |
6.1% |
| Drug Hypersensitivity |
5.6% |
| Tremor |
5.5% |
| Maternal Exposure During Pregnancy |
4.9% |
| Somnolence |
4.1% |
| Serotonin Syndrome |
3.0% |
| Depression |
2.8% |
| Ventricular Septal Defect |
2.8% |
| Completed Suicide |
2.1% |
| Thinking Abnormal |
1.9% |
| White Blood Cell Count Increased |
1.9% |
| Road Traffic Accident |
1.7% |
| Tachycardia |
1.7% |
| Vision Blurred |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.7% |
| Depression |
18.3% |
| Drug Use For Unknown Indication |
9.3% |
| Anxiety |
7.9% |
| Pain |
6.0% |
| Hypertension |
4.9% |
| Bipolar Disorder |
4.8% |
| Multiple Sclerosis |
4.0% |
| Insomnia |
2.6% |
| Sleep Disorder |
2.6% |
| Gastrooesophageal Reflux Disease |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Contraception |
2.1% |
| Hepatitis C |
2.0% |
| Smoking Cessation Therapy |
2.0% |
| Diabetes Mellitus |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Osteoporosis |
1.8% |
| Asthma |
1.8% |
| Crohn's Disease |
1.7% |
|
| Vomiting |
11.8% |
| Weight Increased |
11.3% |
| Weight Decreased |
10.5% |
| Type 2 Diabetes Mellitus |
10.0% |
| Suicidal Ideation |
5.1% |
| Nausea |
4.9% |
| Pain |
4.6% |
| Drug Ineffective |
4.3% |
| Tremor |
4.1% |
| Pulmonary Embolism |
4.0% |
| Vision Blurred |
3.8% |
| Urinary Tract Infection |
3.2% |
| Withdrawal Syndrome |
3.2% |
| Suicide Attempt |
3.2% |
| Somnolence |
3.0% |
| Wrong Technique In Drug Usage Process |
3.0% |
| Rash |
2.9% |
| Pancreatitis |
2.5% |
| Depression |
2.4% |
| Pain In Extremity |
2.2% |
|
| Interacting |
| Depression |
19.6% |
| Product Used For Unknown Indication |
13.8% |
| Drug Use For Unknown Indication |
11.7% |
| Smoking Cessation Therapy |
10.9% |
| Bipolar Disorder |
5.9% |
| Back Pain |
4.4% |
| Hypertension |
3.5% |
| Pain |
3.2% |
| Anxiety |
2.9% |
| Bronchitis |
2.9% |
| Fibromyalgia |
2.9% |
| Sedation |
2.9% |
| Cough |
2.6% |
| Epilepsy |
2.6% |
| Rheumatoid Arthritis |
2.3% |
| Blood Cholesterol Abnormal |
1.8% |
| Immune Reconstitution Syndrome |
1.8% |
| Bipolar I Disorder |
1.5% |
| Nausea |
1.5% |
| Abdominal Discomfort |
1.2% |
|
| Drug Interaction |
23.3% |
| Respiratory Depression |
10.5% |
| Suicide Attempt |
7.0% |
| Thinking Abnormal |
7.0% |
| Surgery |
5.8% |
| Weight Decreased |
5.8% |
| Disorientation |
4.7% |
| Aggression |
3.5% |
| Somnolence |
3.5% |
| Suicidal Ideation |
3.5% |
| Traumatic Haemorrhage |
3.5% |
| Tremor |
3.5% |
| Cerebral Haematoma |
2.3% |
| Electrocardiogram Qt Prolonged |
2.3% |
| Feeling Abnormal |
2.3% |
| Haematoma |
2.3% |
| Hyponatraemia |
2.3% |
| International Normalised Ratio Increased |
2.3% |
| Nausea |
2.3% |
| Pyrexia |
2.3% |
|
